SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

SF3B1 mutations were recently reported in myelodysplastic syndromes (MDSs), especially in the presence of ring sideroblasts (RSs). We sought to define the interaction between SF3B1 mutations, morphology, karyotype, and prognosis in MDS with more than or equal to 15% RS (MDS-RS). We studied 107 patie...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Patnaik, Mrinal M., Lasho, Terra L., Hodnefield, Janice M., Knudson, Ryan A., Ketterling, Rhett P., Garcia-Manero, Guillermo, Steensma, David P., Pardanani, Animesh, Hanson, Curtis A., Tefferi, Ayalew
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2012
Gaiak:
Myeloid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916563/
https://ncbi.nlm.nih.gov/pubmed/22096241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-09-377994
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak